# Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

> **NCT02395666** · PHASE2 · COMPLETED · sponsor: **Giselle Sholler** · enrollment: 140 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** DFMO

## Key facts

- **NCT ID:** NCT02395666
- **Lead sponsor:** Giselle Sholler
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-05
- **Primary completion:** 2018-03-27
- **Final completion:** 2023-08-24
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395666, "Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02395666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*